Develops AI-driven biomolecule stability matrices that enhance the thermal stability, manufacturing efficiency, and administration convenience of biomolecular products. By integrating FDA-approved ingredients into a proprietary molecular network, the platform overcomes challenges in formulation, shelf stability, and supply chain logistics, enabling faster and more reliable market access for healthcare applications.
Funding
$750K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Biomolecules, while increasingly important in healthcare, are inherently complex and fragile, leading to difficulties in manufacturing, formulation, achieving adequate shelf stability, and convenient administration. This complexity hinders the efficient commercialization and widespread adoption of biomolecule-based products.
Solution
AEMS Corp develops AI-driven biomolecule stability matrices, called Agent Delivery Matrices (ADM™), that enhance the thermal stability, manufacturing efficiency, and administration convenience of biomolecular products. The platform uses FDA-approved ingredients in a proprietary molecular network to overcome challenges in formulation, shelf stability, and supply chain logistics. AEMS Corp's high-throughput screening platform allows for the rapid development of tailor-made biostability materials that precisely meet unique needs. The technology integrates easily into existing workflows, lessening the need for additional equipment or training.
Target Audience
The primary target audience includes biotechnology companies, pharmaceutical manufacturers, and agricultural businesses seeking to improve the stability, delivery, and manufacturability of their biomolecule-based products.
Features
- AI-driven high throughput screening platform for rapid development of biostability materials
- Proprietary molecular network using FDA-approved ingredients
- Agent Delivery Matrix (ADM™) technology to improve manufacturing operations, provide greater thermal stability, and overcome concentration and viscosity limitations
- Streamlined integration into existing workflows, minimizing the need for additional equipment or training